Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 57

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 57
---
ance 
     under Equity 
     Compensation 
 Plans (Excluding 
       Securities 
     Reflected in 
      Column (a)) |
|                                                               |     |            -a |     | -b          |     |               -c |
| Equity compensation plans approved by security holders(1)     |     |     6,132,747 |     | $12.77(2)   |     |     1,741,970(3) |
| Equity compensation plans not approved by security holders(4) |     |     1,178,925 |     | $41.42(2)   |     |        71,075(5) |
| Total                                                         |     |     7,311,672 |     | $16.44(2)   |     |        1,813,045 |

| (1) | Consists of the 2017 Plan, the 2021 Plan, and our 2021 Employee Stock Purchase Plan (“ESPP”). The number of shares of our Class A common stock reserved for issuance under the 2021 Plan is subject to an automatic increase on January 1st of each year for a period of 10 years, beginning on January 1, 2022 and continuing through January 1, 2031, in an amount equal to (a) 5% of the total number of shares of Class A common stock outstanding on December 31st of the immediately preceding year or (b) a lesser number of shares of Class A common stock determined by the Board no later than the date of any such increase. The number of shares of our Class A common stock reserved for issuance under the ESPP is subject to an automatic increase on January 1st of each year for a period of 10 years, beginning on January 1, 2022 and continuing through January 1, 2031. The number of shares added each year will be equal to the lesser of: (a) 1% of the total number of shares of our Class A common stock outstanding on December 31st of the preceding calendar year; and (b) 440,502 shares of Class A common stock, except before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (a) and (b). On January 1, 2025, the numbers of shares of our Class A common stock reserved for issuance under the 2021 Plan and